Canaccord Genuity Wealth Limited, acting for discretionary clients, disclosed a 4.2117% interest in Advanced Medical Solutions Group PLC under Rule 8.3 of the Takeover Code (UK takeover disclosure rules). The position comprised 9,312,962 controlled 5p ordinary shares, with no disclosed short positions, derivatives or subscription rights. The filing also recorded sales of 4,975 shares at 281 pence each and 22,267 shares at 281.08 pence each. The position date was September 4, 2026, and the disclosure was dated September 7, 2026.